Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Additional risks include diabetic retinopathy complications (particularly with semaglutide in patients with pre-existing retinopathy), acute kidney injury (especially with volume depletion from gastrointestinal effects), and rare cases of intestinal obstruction or ileus
Proceed with Caution: Dr
The company had received approval from Chinese regulators for its weight-loss drug tirzepatide in July, further intensifying competition with Danish rival Novo Nordisk (NYSE:NVO) in the key Asian market
Key Points to Consider: Initial Phase: During the first few weeks on the medication, some patients may experience more significant weight loss (potentially exceeding 2 pounds per week), especially if they also adopt lifestyle changes such as dietary adjustments and increased physical activity
US$ 26.69
US$ 29.87
US$ 22.15
US$ 23.83
US$ 29.54
